Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients’ Experience on Rifaximin-α (PROSPER): an observational study among 550 patients
Crossref DOI link: https://doi.org/10.1186/s41124-017-0029-9
Published Online: 2018-01-08
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Krag, Aleksander
Schuchmann, Marcus
Sodatonou, Hanna
Pilot, Jeff
Whitehouse, James
Strasser, Simone I.
Hudson, Mark
Funding for this research was provided by:
Norgine Limited